Cardiff Oncology Inc. buy krebskrebs
Start price
16.10.23
/
50%
€1.08
Target price
16.10.24
€1.60
Performance (%)
135.62%
End price
17.10.24
€2.54
Summary
This prediction ended on 17.10.24 with a price of €2.54. With a performance of 135.62% the BUY prediction by krebskrebs was a big success. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Cardiff Oncology Inc. | 2.524% | 2.524% | -52.545% |
| iShares Core DAX® | -3.520% | -4.987% | 1.926% |
| iShares Nasdaq 100 | 0.261% | 1.102% | 15.434% |
| iShares Nikkei 225® | -4.953% | -3.352% | 29.010% |
| iShares S&P 500 | -0.823% | -0.042% | 10.814% |
Comments by krebskrebs for this prediction
In the thread Trovagene diskutieren
In the thread Trading Trovagene
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten